Test HIV medicines for people with new or long-term HIV
Part of Infections clinical trials.
This Phase 3 study looks at antiretroviral treatment (HIV medicines) for adults with either recent (acute) or long-term (chronic) HIV. It’s designed to see how well and safely ongoing HIV treatment works, and it may help you get structured care and monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or older
- You must already be in the study’s SEARCH 010 or 013 program for documented HIV infection
- Be able to understand the study and sign consent (or have it read to you and consent with a thumb print)
- Plan to stay available for follow-up visits for the full study time
- No health or mental health condition that would get in the way of taking the study treatment or following the rules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study enrolls adults with a very recent (“acute”) HIV infection to follow them over time and better understand what happens early after infection. Your participation may help researchers improve how acute HIV is detected and managed.
This study follows people with a very recent HIV infection and collects blood and other samples to learn more about the infection soon after it starts. It may help researchers better understand early HIV and improve future treatments.
This trial tests whether giving two powerful HIV-fighting antibodies (called broadly neutralizing monoclonal antibodies) along with starting standard HIV medications soon after infection can help control the virus without needing daily pills. If successful, it might allow people to take a 'treatment pause' while keeping their immune system healthy.
This Phase 2 trial tests whether adding long-acting HIV antibodies to standard HIV treatment (ART) can help control HIV in people who started ART soon after getting infected. It also checks how safe the antibody treatment is and how well it works over time.
This study is for adults who were recently diagnosed with HIV and are not yet on HIV treatment (ART). It aims to test ways to support care and help people get connected with the right HIV specialists.
This study looks at how certain immune cells (NK cells) behave in people who have been on HIV treatment for a long time. It aims to understand why some people's immune systems respond differently, which could help improve future treatments.
Hear when a new Acute HIV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.